188 related articles for article (PubMed ID: 2760616)
1. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.
Saggu H; Cooksey J; Dexter D; Wells FR; Lees A; Jenner P; Marsden CD
J Neurochem; 1989 Sep; 53(3):692-7. PubMed ID: 2760616
[TBL] [Abstract][Full Text] [Related]
2. Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.
Marttila RJ; Lorentz H; Rinne UK
J Neurol Sci; 1988 Sep; 86(2-3):321-31. PubMed ID: 3221244
[TBL] [Abstract][Full Text] [Related]
3. Superoxide dismutase expression in Parkinson's disease.
Poirier J; Dea D; Baccichet A; Thiffault C
Ann N Y Acad Sci; 1994 Nov; 738():116-20. PubMed ID: 7832421
[No Abstract] [Full Text] [Related]
4. The paradigm that all oxygen-respiring eukaryotes have cytosolic CuZn-superoxide dismutase and that Mn-superoxide dismutase is localized to the mitochondria does not apply to a large group of marine arthropods.
Brouwer M; Brouwer TH; Grater W; Enghild JJ; Thogersen IB
Biochemistry; 1997 Oct; 36(43):13381-8. PubMed ID: 9341231
[TBL] [Abstract][Full Text] [Related]
5. Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease.
Kushleika J; Checkoway H; Woods JS; Moon JD; Smith-Weller T; Franklin GM; Swanson PD
Ann Neurol; 1996 Mar; 39(3):378-81. PubMed ID: 8602757
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
Glover V; Clow A; Sandler M
J Neural Transm Suppl; 1993; 40():37-45. PubMed ID: 8294899
[TBL] [Abstract][Full Text] [Related]
7. Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats.
Carrillo MC; Kanai S; Sato Y; Ivy GO; Kitani K
Biochem Pharmacol; 1992 Dec; 44(11):2185-9. PubMed ID: 1472083
[TBL] [Abstract][Full Text] [Related]
8. Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control.
Shimoda-Matsubayashi S; Hattori T; Matsumine H; Shinohara A; Yoritaka A; Mori H; Kondo T; Chiba M; Mizuno Y
Neurology; 1997 Nov; 49(5):1257-62. PubMed ID: 9371904
[TBL] [Abstract][Full Text] [Related]
9. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
[TBL] [Abstract][Full Text] [Related]
10. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
Li J; Wang LN; Xiao HL; Li X; Yang JJ
Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
[TBL] [Abstract][Full Text] [Related]
11. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Dexter DT; Carter CJ; Wells FR; Javoy-Agid F; Agid Y; Lees A; Jenner P; Marsden CD
J Neurochem; 1989 Feb; 52(2):381-9. PubMed ID: 2911023
[TBL] [Abstract][Full Text] [Related]
12. Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex.
Radunović A; Porto WG; Zeman S; Leigh PN
Neurosci Lett; 1997 Dec; 239(2-3):105-8. PubMed ID: 9469667
[TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase and Parkinson's disease.
Ceballos I; Lafon M; Javoy-Agid F; Hirsch E; Nicole A; Sinet PM; Agid Y
Lancet; 1990 Apr; 335(8696):1035-6. PubMed ID: 1970085
[No Abstract] [Full Text] [Related]
14. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
Kunikowska G; Jenner P
Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease.
Yoritaka A; Hattori N; Mori H; Kato K; Mizuno Y
J Neurol Sci; 1997 May; 148(2):181-6. PubMed ID: 9129114
[TBL] [Abstract][Full Text] [Related]
16. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain.
Mogi M; Togari A; Kondo T; Mizuno Y; Komure O; Kuno S; Ichinose H; Nagatsu T
J Neural Transm (Vienna); 2000; 107(3):335-41. PubMed ID: 10821442
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice.
Przedborski S; Jackson-Lewis V; Kostic V; Carlson E; Epstein CJ; Cadet JL
J Neurochem; 1992 May; 58(5):1760-7. PubMed ID: 1560230
[TBL] [Abstract][Full Text] [Related]
18. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex.
Li H; Dryhurst G
J Neural Transm (Vienna); 2001; 108(12):1363-74. PubMed ID: 11810401
[TBL] [Abstract][Full Text] [Related]
19. Quantitative histochemical assay for superoxide dismutase in rat brain.
Viggiano A; Viggiano D; Viggiano A; De Luca B
J Histochem Cytochem; 2003 Jul; 51(7):865-71. PubMed ID: 12810837
[TBL] [Abstract][Full Text] [Related]
20. The distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal ganglia.
Kunikowska G; Jenner P
Biochem Pharmacol; 2002 Mar; 63(6):1159-64. PubMed ID: 11931849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
